Home » Topics » Regulatory

Regulatory
RSS

FDA approves Akten ophthalmic gel 3.5%

Oct. 9, 2008

European Commission adopts EMEA recommendations for Arcoxia 90 mg

Oct. 2, 2008

Aclasta approved in Europe for osteoporosis in men with high risk of fractures

Oct. 1, 2008

CHMP issues positive opinion for olanzapine long-acting injection in schizophrenia

Sep. 29, 2008

Xarelto approved in Canada for prevention of venous thromboembolic events

Sep. 17, 2008

FDA approves Gamunex for inflammatory demyelinating polyneuropathy

Sep. 17, 2008

Vimpat approved in the E.U. for partial-onset seizures

Sep. 3, 2008

SF-1019 approved in Malaysia

Aug. 13, 2008

FDA approves Cleviprex for hypertension when oral therapy is not feasible

Aug. 5, 2008

European Commission approves Schering-Plough's Bridion

July 30, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...